查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2028330

非侵入性產前檢測市場規模、佔有率、成長和全球產業分析：按類型、應用和地區分類，並對 2026-2034 年進行洞察和預測。

Non-Invasive Prenatal Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

非侵入性產前檢測市場的成長要素

全球非侵入性產前檢測市場預計在2025年達到84.2億美元，2026年成長至99.2億美元，並在2034年達到367.9億美元。由於人們對產前篩檢的認知不斷提高以及基因檢測技術的進步，該市場正經歷快速成長。北美地區擁有完善的醫療基礎設施和先進的診斷解決方案，預計將引領市場，在2025年佔51.62%的市場佔有率。

非侵入式產前檢測 (NIPT) 透過分析母親血液中游離的胎兒 DNA 來檢測染色體異常，例如唐氏症、愛德華氏症候群和巴陶氏症。對早期、準確檢測遺傳疾病的需求日益成長，推動了這些檢測方法在全球的應用。

市場趨勢

一個重要的市場趨勢是從侵入性產前檢測轉向非侵入性檢測。非侵入性檢測因其安全性更高、準確性更強、風險更低，在醫療專業人員和患者中越來越受歡迎。

此外，基因測序技術的不斷進步，特別是次世代定序（NGS）技術，正在提高檢測的準確性和效率。各公司正拓展產品線，並加大研發投入，以開發更先進、更經濟的檢測方案。

市場促進因素

染色體異常和遺傳疾病盛行率的上升是市場成長的主要促進因素。高齡產婦和生活方式的改變導致新生兒遺傳疾病風險增加，進而引發了對早期篩檢日益成長的需求。

此外，已開發地區先進診斷技術的廣泛應用以及有利的保險報銷政策也促進了市場擴張。孕婦及其伴侶對早期檢測益處的認知不斷提高，也推動了市場成長。

抑制因子

非侵入性產前檢測 (NIPT) 的高成本限制了發展中地區的普及，為市場帶來了挑戰。某些地區認知度低、醫療基礎設施不足也進一步阻礙了市場滲透。

此外，不同地區報銷政策的差異以及對檢測費用負擔的擔憂可能會阻礙檢測的廣泛普及。

細分分析

按產品類別分類，耗材和試劑類別佔市場主導地位，這主要得益於全球檢測數量的不斷成長和產品的持續創新。設備類別也因診斷設備的進步而成長。

按技術分類，次世代定序（NGS）技術憑藉其高精度和在染色體異常檢測方面的廣泛應用，佔了最大的市場佔有率。 PCR和微陣列等其他技術也為市場成長做出了貢獻。

按終端用戶分類，配備先進技術且能夠處理大量診斷測試的臨床檢查室是市場的主要驅動力。醫院在支持產前篩檢服務方面也發揮著至關重要的作用。

區域分析

受高滲透率、大型企業強大影響力以及遺傳性疾病盛行率上升的推動，預計北美將保持其領先地位，到2025年市場規模將達到43.5億美元。美國正透過持續創新和投資診斷技術，在鞏固其區域主導地位方面發揮關鍵作用。

在歐洲，由於有利的報銷政策以及NIPT被納入公共醫療體系，該地區的NIPT市場呈現顯著成長。亞太地區成長最快，這得益於醫療基礎設施的改善、公眾意識的提高以及中國和印度等國家龐大的患者群體。拉丁美洲、中東和非洲地區也正經歷著穩定成長，這主要歸功於人們對非侵入性檢測方法的認知不斷提高和應用日益廣泛。

主要公司及趨勢

包括Illumina、Naterra、LabCorp、羅氏和Eurofins LifeCodex在內的領導企業正致力於拓展產品系列加強全球影響力。這些公司正加大研發投入，以推出創新且精準的檢測解決方案。

近期趨勢包括產品發布、策略聯盟和收購，旨在增強技術能力和擴大市場覆蓋率。對精準診斷領域的投資增加，進一步推動了市場創新。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 非侵入性產前檢測（NIPT）技術的進步
  • 2021/2025年主要公司/地區進行的NIPT檢測數量
  • 產業重大發展－併購等。
  • 新冠疫情的影響：非侵入性產前檢測市場

第5章：2021-2034年全球無創產前檢測市場分析、洞察與預測

  • 市場分析、洞察與預測：按產品分類。
    • 耗材和試劑
    • 裝置
  • 市場分析、洞察與預測：按技術分類
    • 次世代定序（NGS）
    • 微陣列
    • 聚合酵素鏈鎖反應（PCR）
    • 滾動循環放大
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院
    • 診斷檢查室
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美非侵入性產前檢測市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲非侵入性產前檢測市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區非侵入性產前檢測市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲無創產前檢測市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲非侵入性產前檢測市場分析、洞察與預測（2021-2034年）

  • 國家
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Illumina, Inc.
    • YOURGENE HEALTH
    • Natera
    • F. Hoffmann-La Roche Ltd
    • PerkinElmer Inc.
    • Laboratory Corporation of America
    • Eurofins LifeCodexx GmbH
    • Other Players
Product Code: FBI100998

Growth Factors of non-invasive prenatal testing Market

The global non-invasive prenatal testing market was valued at USD 8.42 billion in 2025 and increased to USD 9.92 billion in 2026, with projections reaching USD 36.79 billion by 2034. The market is experiencing rapid expansion due to increasing awareness of prenatal screening and advancements in genetic testing technologies. North America dominated the market with a 51.62% share in 2025, supported by strong healthcare infrastructure and high adoption of advanced diagnostic solutions.

Non-invasive prenatal testing (NIPT) is used to detect chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome by analyzing cell-free fetal DNA in maternal blood. The growing need for early and accurate detection of genetic disorders is driving the adoption of these tests globally.

Market Trends

A significant trend in the market is the shift from invasive to non-invasive prenatal testing methods. Non-invasive tests offer higher safety, accuracy, and reduced risk compared to traditional invasive procedures, leading to increased adoption among healthcare providers and patients.

Additionally, continuous technological advancements in genomic sequencing, particularly next-generation sequencing (NGS), are improving test accuracy and efficiency. Companies are expanding their product portfolios and investing in research to develop more advanced and cost-effective testing solutions.

Driving Factors

The rising prevalence of chromosomal abnormalities and genetic disorders is a key factor driving market growth. Increasing maternal age and changing lifestyle factors have contributed to higher risks of genetic conditions in newborns, increasing the demand for early screening.

Furthermore, the growing adoption of advanced diagnostic technologies and favorable reimbursement policies in developed regions are supporting market expansion. Increasing awareness among expectant parents regarding the benefits of early detection is also contributing to market growth.

Restraining Factors

The market faces challenges due to the high cost of non-invasive prenatal tests, which limits accessibility in developing regions. The lack of awareness and limited healthcare infrastructure in certain areas further restrict market penetration.

Additionally, variations in reimbursement policies across regions and concerns regarding test affordability may hinder widespread adoption.

Segmentation Analysis

By product, the consumables and reagents segment dominates the market, driven by the increasing number of tests conducted globally and continuous product innovations. The instruments segment is also growing due to advancements in diagnostic equipment.

By technology, the next-generation sequencing (NGS) segment holds the largest share, supported by its high accuracy and widespread use in detecting chromosomal abnormalities. Other technologies such as PCR and microarray also contribute to market growth.

By end-user, clinical laboratories lead the market, as they are equipped with advanced technologies and handle a large volume of diagnostic tests. Hospitals also play a significant role in supporting prenatal screening services.

Regional Analysis

North America leads the market with a value of USD 4.35 billion in 2025, driven by high adoption rates, strong presence of key players, and increasing prevalence of genetic disorders. The United States plays a major role in regional dominance due to continuous innovation and investment in diagnostic technologies.

Europe is experiencing significant growth due to supportive reimbursement policies and integration of NIPT into public healthcare systems. Asia Pacific is the fastest-growing region, supported by improving healthcare infrastructure, rising awareness, and a large patient population in countries such as China and India. Latin America and the Middle East & Africa are also witnessing gradual growth due to increasing awareness and adoption of non-invasive testing methods.

Key Industry Players and Developments

Leading companies such as Illumina, Natera, LabCorp, F. Hoffmann-La Roche, and Eurofins LifeCodexx are focusing on expanding their product portfolios and strengthening their global presence. These companies are investing in research and development to introduce innovative and accurate testing solutions.

Recent developments include product launches, strategic collaborations, and acquisitions aimed at enhancing technological capabilities and expanding market reach. Increasing investments in precision diagnostics are further driving innovation in the market.

Conclusion

The non-invasive prenatal testing market is projected to grow from USD 8.42 billion in 2025 to USD 36.79 billion by 2034, driven by increasing demand for early detection of genetic disorders and advancements in diagnostic technologies. While high costs and limited accessibility pose challenges, continuous innovation, rising awareness, and supportive healthcare policies will sustain strong market growth in the coming years.

Segmentation By Product, Technology, End User, and Region

By Product * Consumables & Reagents

  • Instruments

By Technology

Next Generation Sequencing (NGS)

  • Microarray
  • Polymerase Chain Reaction (PCR)
  • Rolling Circular Amplification

By End User * Hospitals

  • Clinical Laboratories

By Region * North America (By Product, By Technology, By End User, and By Country)

    • U.S. (By Product)
    • Canada (By Product)
  • Europe (By Product, By Technology, By End User, and By Country)
    • U.K. (By Product)
    • Germany (By Product)
    • France (By Product)
    • Italy (By Product)
    • Spain (By Product)
    • Rest of Europe (By Product)
  • Asia Pacific (By Product, By Technology, By End User, and By Country)
    • China (By Product)
    • Japan (By Product)
    • India (By Product)
    • Australia (By Product)
    • Southeast Asia (By Product)
    • Rest of Asia Pacific (By Product)
  • Latin America (By Product, By Technology, By End User, and By Country)
    • Brazil (By Product)
    • Mexico (By Product)
    • Rest of Latin America (By Product)
  • Middle East & Africa (By Product, By Technology, By End User, and By Country)
    • GCC (By Product)
    • South Africa (By Product)
    • Rest of Middle East & Africa (By Product)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Non-invasive Prenatal Testing (NIPT) Techniques
  • 4.2. Number of NIPT Tests Performed, Key Players/ Region, 2021/2025
  • 4.3. Key Industry Developments - Mergers, Acquisitions, Etc.
  • 4.4. Impact of COVID-19 on Non-invasive Prenatal Testing Market

5. Global Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Consumables & Reagents
    • 5.1.2. Instruments
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Next Generation Sequencing (NGS)
    • 5.2.2. Microarray
    • 5.2.3. Polymerase Chain Reaction (PCR)
    • 5.2.4. Rolling Circular Amplification
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Diagnostic Laboratories
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Consumables & Reagents
    • 6.1.2. Instruments
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Next Generation Sequencing (NGS)
    • 6.2.2. Microarray
    • 6.2.3. Polymerase Chain Reaction (PCR)
    • 6.2.4. Rolling Circular Amplification
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Diagnostic Laboratories
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Product
    • 6.4.2. Canada
      • 6.4.2.1. By Product

7. Europe Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Consumables & Reagents
    • 7.1.2. Instruments
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Next Generation Sequencing (NGS)
    • 7.2.2. Microarray
    • 7.2.3. Polymerase Chain Reaction (PCR)
    • 7.2.4. Rolling Circular Amplification
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Laboratories
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. U.K.
      • 7.4.1.1. By Product
    • 7.4.2. Germany
      • 7.4.2.1. By Product
    • 7.4.3. France
      • 7.4.3.1. By Product
    • 7.4.4. Spain
      • 7.4.4.1. By Product
    • 7.4.5. Italy
      • 7.4.5.1. By Product
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Product
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Product

8. Asia pacific Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Consumables & Reagents
    • 8.1.2. Instruments
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Next Generation Sequencing (NGS)
    • 8.2.2. Microarray
    • 8.2.3. Polymerase Chain Reaction (PCR)
    • 8.2.4. Rolling Circular Amplification
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Laboratories
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
      • 8.4.1.1. By Product
    • 8.4.2. China
      • 8.4.2.1. By Product
    • 8.4.3. India
      • 8.4.3.1. By Product
    • 8.4.4. Australia
      • 8.4.4.1. By Product
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Product
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Product

9. Latin America Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Consumables & Reagents
    • 9.1.2. Instruments
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Next Generation Sequencing (NGS)
    • 9.2.2. Microarray
    • 9.2.3. Polymerase Chain Reaction (PCR)
    • 9.2.4. Rolling Circular Amplification
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Laboratories
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
      • 9.4.1.1. By Product
    • 9.4.2. Mexico
      • 9.4.2.1. By Product
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Product

10. Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Consumables & Reagents
    • 10.1.2. Instruments
  • 10.2. Market Analysis, Insights and Forecast - By Technology
    • 10.2.1. Next Generation Sequencing (NGS)
    • 10.2.2. Microarray
    • 10.2.3. Polymerase Chain Reaction (PCR)
    • 10.2.4. Rolling Circular Amplification
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Laboratories
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC Countries
      • 10.4.1.1. By Product
    • 10.4.2. South Africa
      • 10.4.2.1. By Product
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Product

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Illumina, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. YOURGENE HEALTH
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Natera
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. F. Hoffmann-La Roche Ltd
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. PerkinElmer Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Laboratory Corporation of America
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Eurofins LifeCodexx GmbH
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Other Players

List of Tables

  • Table 1: Global Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 3: Global Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 4: Global Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 6: U.S Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 7: Canada Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 8: North America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 9: North America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 10: Europe Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 11: Germany Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 12: U.K Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 13: France Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Italy Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 15: Spain Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 16: Scandinavia Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 17: Rest of Europe Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 18: Europe Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 19: Europe Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 20: Europe Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 22: Japan Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 23: China Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 24: India Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 25: Australia Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 26: South East Asia Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 27: Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 28: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 29: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Latin America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 32: Brazil Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 33: Mexico Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 34: Rest of Latin America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 35: Latin America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 36: Latin America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 37: Latin America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 38: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 39: GCC Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 40: South Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 41: Rest of Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 42: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 43: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 44: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Non-invasive Prenatal Testing (NIPT) Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Instruments, 2025-2034
  • Figure 4: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Consumables & Reagents, 2025-2034
  • Figure 5: Global Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025 & 2034
  • Figure 6: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by PCR, 2025-2034
  • Figure 7: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Microarray, 2025-2034
  • Figure 8: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by NGS, 2025-2034
  • Figure 9: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Roller Circular Amplification, 2025-2034
  • Figure 10: Global Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025 & 2034
  • Figure 11: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Hospitals, 2025-2034
  • Figure 12: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Clinical Laboratories, 2025-2034
  • Figure 13: Global Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Region, 2025 & 2034
  • Figure 14: North America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Product, 2025 & 2034
  • Figure 15: North America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025
  • Figure 16: North America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 17: North America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025
  • Figure 18: North America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: North America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025
  • Figure 20: North America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), By Country, 2025 & 2034
  • Figure 21: North America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Country, 2025
  • Figure 22: Europe Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Product, 2025 & 2034
  • Figure 23: Europe Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025
  • Figure 24: Europe Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 25: Europe Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025
  • Figure 26: Europe Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Europe Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025
  • Figure 28: Europe Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Europe Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Product, 2025 & 2034
  • Figure 31: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025
  • Figure 32: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 33: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025
  • Figure 34: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025
  • Figure 36: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Latin America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Product, 2025 & 2034
  • Figure 39: Latin America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025
  • Figure 40: Latin America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 41: Latin America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025
  • Figure 42: Latin America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Latin America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025
  • Figure 44: Latin America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Latin America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Product, 2025 & 2034
  • Figure 47: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025
  • Figure 48: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 49: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025
  • Figure 50: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 51: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025
  • Figure 52: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 53: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 54: Global Non-invasive Prenatal Testing (NIPT) Market Share (%), By Company, 2025